Many seniors may be unaware of the landmark coverage shift starting on July 1, with limited advertising seen from the government or Eli Lilly and Novo.
Starting July 1, Medicare will offer landmark coverage for obesity drugs, marking a significant shift for seniors. However, many eligible individuals remain unaware of this new benefit, as there has been limited public advertising from the government or key pharmaceutical…
Market Samachar is a news aggregator. This article was originally published by Business News. Tap the button above to read the full story on their site.